메뉴 건너뛰기




Volumn 9, Issue 7, 1996, Pages 715-717

Hypertension and how to treat it: Studies good and bad and a strategic suggestion

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION;

EID: 0030197974     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00200-2     Document Type: Editorial
Times cited : (1)

References (8)
  • 1
    • 0029161079 scopus 로고
    • The risk of myocardial infarction associated with antihypertensive drug therapies
    • 1. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274(8):220-625.
    • (1995) JAMA , vol.274 , Issue.8 , pp. 220-625
    • Psaty, B.M.1    Heckbert, S.R.2    Koepsell, T.D.3
  • 2
    • 0028799128 scopus 로고
    • Immediate management 6f severe hypertension. Cardiology clinics
    • 2. Ram CVS: Immediate management 6f severe hypertension. Cardiology clinics. Hypertension 1995;13(4):579-591.
    • (1995) Hypertension , vol.13 , Issue.4 , pp. 579-591
    • Ram, C.V.S.1
  • 3
    • 0024447786 scopus 로고
    • Monotherapy of stable angina with nicardipine hydrochloride: Double-blind, placebo-controlled, randomized study
    • 3. Gheorghiade M, Weiner DA, Chakko S, et al: Monotherapy of stable angina with nicardipine hydrochloride: double-blind, placebo-controlled, randomized study. Eur Heart J 1989;10:695-701.
    • (1989) Eur Heart J , vol.10 , pp. 695-701
    • Gheorghiade, M.1    Weiner, D.A.2    Chakko, S.3
  • 4
    • 84936498625 scopus 로고
    • Calcium antagonists increased recurrent myocardial infarction
    • 4. Takenaka T, et al: Calcium antagonists increased recurrent myocardial infarction (abst). Circulation 1993;88(4 part2):I297.
    • (1993) Circulation , vol.88 , Issue.4 PART 2
    • Takenaka, T.1
  • 5
    • 0029132121 scopus 로고
    • Nifedipine: Dose-related increase in mortality with patients with coronary heart disease
    • 5. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality with patients with coronary heart disease. Circulation 1995;92:1326-1331.
    • (1995) Circulation , vol.92 , pp. 1326-1331
    • Furberg, C.D.1    Psaty, B.M.2    Meyer, J.V.3
  • 6
    • 0029921854 scopus 로고    scopus 로고
    • Hypertension and outcomes research: From clinical trials to clinical epidemiology
    • 6. Psaty BM, Siscovick DS, Weiss NS, et al: Hypertension and outcomes research: from clinical trials to clinical epidemiology. Am J Hypertens 1996;9(2):178-183.
    • (1996) Am J Hypertens , vol.9 , Issue.2 , pp. 178-183
    • Psaty, B.M.1    Siscovick, D.S.2    Weiss, N.S.3
  • 7
    • 0018821869 scopus 로고
    • Magnesium and calcium in the myocardium: Cause of death and area differences
    • 7. Elwood PC, Sweetnam PM, Bealey WH, et al: Magnesium and calcium in the myocardium: cause of death and area differences. Lancet 1980;ii:720-722.
    • (1980) Lancet , vol.2 , pp. 720-722
    • Elwood, P.C.1    Sweetnam, P.M.2    Bealey, W.H.3
  • 8
    • 0028932732 scopus 로고
    • A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
    • Fourth International Study of Infarct Survival
    • 8. ISIS-4 Collaborative Group: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Fourth International Study of Infarct Survival. Lancet 1995; 345:669-695.
    • (1995) Lancet , vol.345 , pp. 669-695


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.